Injection So when youre giving these injections, they are subcutaneous (SQ) injections, meaning they need to stay in the fatty tissue
Finally, publication bias cannot be excluded, especially given the increasing clinical interest in GLP-1RAs and the greater likelihood of publishing studies with favorable outcomes
Alternative GLP-1 formulations, dose adjustments, or switching to different weight loss medications may be appropriate
It should be noted that direct comparisons between retatrutide and other agents such as semaglutide or tirzepatide are not straightforward, as trials differ in design, population, duration, and endpoints
Proglucagon Processing The process of generating active GLP-1 is referred to as proglucagon processing
Breast Cancer Res Tr